Elicio Therapeutics (9HA.STU) Q2 2026 Earnings

11MayConfirmed
Q2 2026
-0.55
-0.5
-0.45
-0.39

Details

Expected EPS
-0.39478035000000006
Actual EPS
-0.5518435
Surprise EPS
-0.16
Surprise Percent
+39.78%

Description

Elicio Therapeutics (9HA.STU) has reported earnings of -0.5518435 per share for Q2 2026.

0 Comments

Share your thoughts